Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model
(Q44287903)
scientific article published in January 2003
scientific article published in January 2003
Language:
Current Data About
Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model
other details
| description | scientific article published in January 2003 |
External Links
| (P356) |
10.1046/J.1463-1326.2003.00240.X
|
| (P698) |
12542724
|